GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (LTS:0GZX) » Definitions » Ending Cash Position

Diasorin SpA (LTS:0GZX) Ending Cash Position : €256 Mil (As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Ending Cash Position?

Diasorin SpA's Ending Cash Position for the quarter that ended in Jun. 2024 was €256 Mil.

Diasorin SpA's quarterly Ending Cash Position increased from Dec. 2023 (€280 Mil) to Mar. 2024 (€308 Mil) but then declined from Mar. 2024 (€308 Mil) to Jun. 2024 (€256 Mil).

Diasorin SpA's annual Ending Cash Position declined from Dec. 2021 (€403 Mil) to Dec. 2022 (€242 Mil) but then increased from Dec. 2022 (€242 Mil) to Dec. 2023 (€280 Mil).

Diasorin SpA Ending Cash Position Historical Data

The historical data trend for Diasorin SpA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Ending Cash Position Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 157.55 339.88 403.02 241.78 280.31

Diasorin SpA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 243.00 280.31 308.00 256.00 223.00

Diasorin SpA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Diasorin SpA's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=241.775+38.539
=280

Diasorin SpA's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=373+-117
=256

Diasorin SpA Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (LTS:0GZX) » Definitions » Ending Cash Position
Comparable Companies
TMO DHR XSWX:LONN A IQV IDXX MTD WAT SHSE:603259 ILMN NTRA LH ICLR DGX RVTY XPAR:BIM EXAS MEDP QGEN XPAR:ERF
Traded in Other Exchanges
DIA:Italy DIAm:UK 34D:Germany DIAS:Austria
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Website
https://www.diasoringroup.com
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines